Yuxian He

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Topics

Men Who Have Sex With Men

Respiratory Syndrome Coronavirus

Top Venues

Science advances

Journal of virology

This page only lists publications with an associated author ORCID identifier.

Publications

Hongliang Jin, Lin Cheng, Yani Gong, Yuanmei Zhu, Huihui Chong, Zheng Zhang, Yuxian He
Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein. Journal of virology (2023)
Hongliang Jin, Yani Gong, Lin Cheng, Yuanmei Zhu, Zheng Zhang, Yuxian He
Susceptibility and Resistance of SARS-CoV-2 Variants to LCB1 and Its Multivalent Derivatives. Viruses 16 (1) (2023)
Hongliang Jin, Yani Gong, Lin Cheng, Yuanmei Zhu, Zheng Zhang, Yuxian He
Susceptibility and Resistance of SARS-CoV-2 Variants to LCB1 and Its Multivalent Derivatives. Viruses 16 (1) (2023)
Hongliang Jin, Yani Gong, Lin Cheng, Yuanmei Zhu, Zheng Zhang, Yuxian He
Susceptibility and Resistance of SARS-CoV-2 Variants to LCB1 and Its Multivalent Derivatives. Viruses 16 (1) (2023)
Hongliang Jin, Yani Gong, Lin Cheng, Yuanmei Zhu, Zheng Zhang, Yuxian He
Susceptibility and Resistance of SARS-CoV-2 Variants to LCB1 and Its Multivalent Derivatives. Viruses 16 (1) (2023)
Hongliang Jin, Yani Gong, Lin Cheng, Yuanmei Zhu, Zheng Zhang, Yuxian He
Susceptibility and Resistance of SARS-CoV-2 Variants to LCB1 and Its Multivalent Derivatives. Viruses 16 (1) (2023)
Hongliang Jin, Yani Gong, Lin Cheng, Yuanmei Zhu, Zheng Zhang, Yuxian He
Susceptibility and Resistance of SARS-CoV-2 Variants to LCB1 and Its Multivalent Derivatives. Viruses 16 (1) (2023)
Yue Hu, Wenjiang Yu, Xiuzhu Geng, Yuanmei Zhu, Huihui Chong, Yuxian He
In Vitro Selection and Characterization of HIV-1 Variants with Increased Resistance to LP-40, Enfuvirtide-Based Lipopeptide Inhibitor. International journal of molecular sciences 23 (12) (2022)
Yuanmei Zhu, Danwei Yu, Yue Hu, Tong Wu, Huihui Chong, Yuxian He
SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses. Signal transduction and targeted therapy 6 (1) (2021)
Yuanmei Zhu, Danwei Yu, Yang Han, Hongxia Yan, Huihui Chong, Lili Ren, Jianwei Wang, Tai-Sheng Li, Yuxian He
Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals. Science advances 6 (45) (2020)
Huamian Wei, Danwei Yu, Xiuzhu Geng, Yuxian He
Defective HIV-1 envelope gene promotes the evolution of the infectious strain through recombination in vitro. BMC infectious diseases 20 (1) (2020)
Danwei Yu, Yang Su, Xiaohui Ding, Yuanmei Zhu, Bo Qin, Huihui Chong, Sheng Cui, Yuxian He
Structural and Functional Characterization of the Secondary Mutation N126K Selected by Various HIV-1 Fusion Inhibitors. Viruses 12 (3) (2020)
Huihui Chong, Jing Xue, Yuanmei Zhu, Zhe Cong, Ting Chen, Qiang Wei, Chuan Qin, Yuxian He
Monotherapy with a low-dose lipopeptide HIV fusion inhibitor maintains long-term viral suppression in rhesus macaques. PLoS pathogens 15 (2) (2019)